Find us on
Recent news
CardioWise Named Rising Star at the UCSF Health Awards
November 2022
The University of California San Francisco (UCSF) Health Awards named CardioWise, Inc. as a Rising Star in the Clinical Diagnostic Tool category. The awards highlight the health tech industry, showcasing the best new products and technologies in digital health and life sciences.
CardioWise Featured on the Accelerating Digitally Enabled Care in North America Panel at RSNA
November 2022
CardioWise, Inc. Named a Finalist in the Rising Star Clinical Diagnostics Tool or Platform Category by UCSF Health Hub
October 2022
The University of California San Francisco (UCSF) Health Hub has selected CardioWise, Inc. as a Digital Health Awards Finalist in the Rising Star Clinical Diagnostics Tool or Platform category. The UCSF Health Hub Digital Health Awards recognizes the achievements of innovative health tech companies that are dramatically improving healthcare through the use of technology in the digital health industry.
GE Healthcare in Collaboration with Nex Cubed Select Six Digital Health Start-ups for Inaugural Edison Accelerator in Canada
August 2022
Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector.
CardioWise Receives ISO 13485:2016 Clearance for Design, Development, and Marketing of Software as a Medical Device (SaMD) For the Medical Device Industry
August 2022
CardioWise, Inc., is pleased to announce that Perry Johnson Registrars, Incorporated has audited the CardioWise Quality Management System (QMS) and determined CardioWise is in conformance with ISO 13485:2016.
CardioWise Joins the Lucem Health Innovation Collaborative as a Founding Member
June 2022
CardioWise® and Lucem Health™ announced that CardioWise has become a founding member of the Lucem Health Innovation Collaborative, a partner program designed to help AI/ML innovation move to the forefront of healthcare. The collaborative launched by Mayo Clinic along with other investing partners will help digital health innovators create, deploy, and commercialize transformational solutions powered by artificial intelligence and machine learning models.
CardioWise Named Quarterfinalists at the UCSF Health Awards
September 2021
The University of California San Francisco (UCSF) Health Awards has selected CardioWise, Inc. as a Quarterfinalist in the Hospital Diagnostics Category. The awards showcase the health tech industry, showcasing the best new products and technologies in digital health and life sciences. These are the technologies that will define the future of healthcare and are supported by the nation's top health care accelerators, venture capitalists, and academic leaders.
CardioWise Receives US FDA 510(k) Clearance for Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ®) Heart Function Analysis Software
January 2021
The 510(k) premarket notification letter indicates that the FDA has determined that SQuEEZ may be legally marketed in interstate commerce according to its indications for use. SQuEEZ is an image analysis software application for cardiac Computer Tomography (CT) studies to assist cardiologists and radiologists in assessing function when producing a cardiac evaluation.The software calculates a Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) value to highlight and color code motions of the heart wall. Additional tools are provided to display regional motion properties of the heart.
CardioWise Named a Top-Ten Finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub
October 2019
The University of California San Francisco (UCSF) Health Hub has selected CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. The goal of UCSF Digital Health Awards was to select companies that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital stays, reduced patient and insurer costs, faster cures, and happier doctors and patients. The awards are intended to showcase new technologies that are dramatically improving healthcare through innovative means, to benefit society and to reduce the onerous cost burden. Over 500 companies participated, representing thirteen categories, with over 100 judges.